• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

PET avoids liver resection in colon cancer patients

Article

A multicenter prospective trial in the Netherlands has found that FDG-PET prevents unnecessary surgeries for one in six patients with metastatic colon cancer who undergo liver resection based on CT findings.

A multicenter prospective trial in the Netherlands has found that FDG-PET prevents unnecessary surgeries for one in six patients with metastatic colon cancer who undergo liver resection based on CT findings.

Dr. W.J.G. Oyen of Radboud University Nijmegen Medical Center and colleagues enrolled 75 surgical candidates randomly selected for assessment with CT alone, the standard imaging for recommending surgery, and another 75 who were evaluated with CT and FDG-PET. All 75 patients in the CT group underwent laparotomy compared to 70 in the PET group. Overall, surgeries for 34 (45%) and 21 (28%) patients performed on the basis of CT or CT plus PET, respectively, were considered futile. Disease recurred within six months in almost a third of patients in the CT-only group. Oyen presented results at the 2008 SNM meeting in New Orleans.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.